197 related articles for article (PubMed ID: 15879414)
21. Surfactant protein B polymorphisms, pulmonary function and COPD in 10,231 individuals.
Bækvad-Hansen M; Nordestgaard BG; Dahl M
Eur Respir J; 2011 Apr; 37(4):791-9. PubMed ID: 20693256
[TBL] [Abstract][Full Text] [Related]
22. E-cadherin gene polymorphisms in asthma patients using inhaled corticosteroids.
Ierodiakonou D; Postma DS; Koppelman GH; Boezen HM; Gerritsen J; Ten Hacken N; Timens W; Vonk JM
Eur Respir J; 2011 Nov; 38(5):1044-52. PubMed ID: 21540309
[TBL] [Abstract][Full Text] [Related]
23. β2-adrenergic receptor polymorphisms, asthma and COPD: two large population-based studies.
Thomsen M; Nordestgaard BG; Sethi AA; Tybjærg-Hansen A; Dahl M
Eur Respir J; 2012 Mar; 39(3):558-66. PubMed ID: 22075484
[TBL] [Abstract][Full Text] [Related]
24. Surfactant protein-B 121ins2 heterozygosity, reduced pulmonary function, and chronic obstructive pulmonary disease in smokers.
Baekvad-Hansen M; Dahl M; Tybjaerg-Hansen A; Nordestgaard BG
Am J Respir Crit Care Med; 2010 Jan; 181(1):17-20. PubMed ID: 19833825
[TBL] [Abstract][Full Text] [Related]
25. ABCC1 polymorphisms contribute to level and decline of lung function in two population-based cohorts.
Siedlinski M; Boezen HM; Boer JM; Smit HA; Postma DS
Pharmacogenet Genomics; 2009 Sep; 19(9):675-84. PubMed ID: 19687781
[TBL] [Abstract][Full Text] [Related]
26. Association between CRHR1 polymorphism and improved lung function in response to inhaled corticosteroid in patients with COPD.
Kim WJ; Sheen SS; Kim TH; Huh JW; Lee JH; Kim EK; Lee JH; Lee SM; Lee S; Lim SY; Shin TR; Yoon HI; Oh YM; Lee SD
Respirology; 2009 Mar; 14(2):260-3. PubMed ID: 19210659
[TBL] [Abstract][Full Text] [Related]
27. Lower FEV1 in non-COPD, nonasthmatic subjects: association with smoking, annual decline in FEV1, total IgE levels, and TSLP genotypes.
Masuko H; Sakamoto T; Kaneko Y; Iijima H; Naito T; Noguchi E; Hirota T; Tamari M; Hizawa N
Int J Chron Obstruct Pulmon Dis; 2011; 6():181-9. PubMed ID: 21468164
[TBL] [Abstract][Full Text] [Related]
28. Socioeconomic risk factors for lung function decline in a general population.
Johannessen A; Eagan TM; Omenaas ER; Bakke PS; Gulsvik A
Eur Respir J; 2010 Sep; 36(3):480-7. PubMed ID: 20150201
[TBL] [Abstract][Full Text] [Related]
29. Adam33 polymorphisms are associated with COPD and lung function in long-term tobacco smokers.
Sadeghnejad A; Ohar JA; Zheng SL; Sterling DA; Hawkins GA; Meyers DA; Bleecker ER
Respir Res; 2009 Mar; 10(1):21. PubMed ID: 19284602
[TBL] [Abstract][Full Text] [Related]
30. ADAM33 gene polymorphisms and mortality. A prospective cohort study.
Figarska SM; Vonk JM; van Diemen CC; Postma DS; Boezen HM
PLoS One; 2013; 8(7):e67768. PubMed ID: 23861802
[TBL] [Abstract][Full Text] [Related]
31. Polymorphisms in IL13 pathway genes in asthma and chronic obstructive pulmonary disease.
Beghé B; Hall IP; Parker SG; Moffatt MF; Wardlaw A; Connolly MJ; Fabbri LM; Ruse C; Sayers I
Allergy; 2010 Apr; 65(4):474-81. PubMed ID: 19796199
[TBL] [Abstract][Full Text] [Related]
32. Estrogen receptor 1 polymorphisms are associated with airway hyperresponsiveness and lung function decline, particularly in female subjects with asthma.
Dijkstra A; Howard TD; Vonk JM; Ampleford EJ; Lange LA; Bleecker ER; Meyers DA; Postma DS
J Allergy Clin Immunol; 2006 Mar; 117(3):604-11. PubMed ID: 16522460
[TBL] [Abstract][Full Text] [Related]
33. Lung function decline and outcomes in an adult population.
Mannino DM; Reichert MM; Davis KJ
Am J Respir Crit Care Med; 2006 May; 173(9):985-90. PubMed ID: 16439715
[TBL] [Abstract][Full Text] [Related]
34. Polymorphisms in a disintegrin and metalloprotease 33 gene and the risk of chronic obstructive pulmonary disease: a meta-analysis.
Zhang R; Li H; Zhao H; Chen W; Cheng D
Respirology; 2014 Apr; 19(3):312-20. PubMed ID: 24422987
[TBL] [Abstract][Full Text] [Related]
35. ADAM33 is not associated with asthma in Puerto Rican or Mexican populations.
Lind DL; Choudhry S; Ung N; Ziv E; Avila PC; Salari K; Ha C; Lovins EG; Coyle NE; Nazario S; Casal J; Torres A; Rodriguez-Santana JR; Matallana H; Lilly CM; Salas J; Selman M; Boushey HA; Weiss ST; Chapela R; Ford JG; Rodriguez-Cintron W; Silverman EK; Sheppard D; Kwok PY; González Burchard E
Am J Respir Crit Care Med; 2003 Dec; 168(11):1312-6. PubMed ID: 12958057
[TBL] [Abstract][Full Text] [Related]
36. Variants of asthma and chronic obstructive pulmonary disease genes and lung function decline in aging.
Poon AH; Houseman EA; Ryan L; Sparrow D; Vokonas PS; Litonjua AA
J Gerontol A Biol Sci Med Sci; 2014 Jul; 69(7):907-13. PubMed ID: 24253534
[TBL] [Abstract][Full Text] [Related]
37. Polymorphisms of interleukin-10 and its receptor and lung function in COPD.
He JQ; Shumansky K; Zhang X; Connett JE; Anthonisen NR; Sandford AJ
Eur Respir J; 2007 Jun; 29(6):1120-6. PubMed ID: 17331973
[TBL] [Abstract][Full Text] [Related]
38. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up.
Contoli M; Baraldo S; Marku B; Casolari P; Marwick JA; Turato G; Romagnoli M; Caramori G; Saetta M; Fabbri LM; Papi A
J Allergy Clin Immunol; 2010 Apr; 125(4):830-7. PubMed ID: 20227753
[TBL] [Abstract][Full Text] [Related]
39. Association of ADAM33 polymorphisms with childhood asthma in a northern Chinese population.
Qu S; Sun D; Wang Y; Zhang C; Lv Y; Yao L
Exp Mol Pathol; 2011 Dec; 91(3):775-9. PubMed ID: 21930123
[TBL] [Abstract][Full Text] [Related]
40. The progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohort.
Casanova C; de Torres JP; Aguirre-Jaíme A; Pinto-Plata V; Marin JM; Cordoba E; Baz R; Cote C; Celli BR
Am J Respir Crit Care Med; 2011 Nov; 184(9):1015-21. PubMed ID: 21836135
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
